196 related articles for article (PubMed ID: 32993581)
1. Relationship of possible biomarkers with malignancy of thymic tumors: a meta-analysis.
Zeng H; Yang W; Xu B; Zou J; Su C; Zhong B; Zhu H; Chen Z
BMC Cancer; 2020 Sep; 20(1):928. PubMed ID: 32993581
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems.
Ma Y; Li Q; Cui W; Miao N; Liu X; Zhang W; Zhang C; Wang J
Diagn Pathol; 2012 Sep; 7():120. PubMed ID: 22974165
[TBL] [Abstract][Full Text] [Related]
3. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study.
Omasa M; Date H; Sozu T; Sato T; Nagai K; Yokoi K; Okamoto T; Ikeda N; Tanaka F; Maniwa Y;
Cancer; 2015 Apr; 121(7):1008-16. PubMed ID: 25565590
[TBL] [Abstract][Full Text] [Related]
4. The potential role of bcl-2, bax, and Ki67 expression in thymus of patients with myasthenia gravis, and their correlation with clinicopathologic parameters.
Salakou S; Tsamandas AC; Bonikos DS; Papapetropoulos T; Dougenis D
Eur J Cardiothorac Surg; 2001 Oct; 20(4):712-21. PubMed ID: 11574213
[TBL] [Abstract][Full Text] [Related]
5. Proliferative activity and apoptosis in thymic epithelial neoplasms.
Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
[TBL] [Abstract][Full Text] [Related]
6. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.
Pan CC; Chen PC; Wang LS; Lee JY; Chiang H
Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732
[TBL] [Abstract][Full Text] [Related]
7. Expression and mutational status of c-kit in thymic epithelial tumors.
Petrini I; Zucali PA; Lee HS; Pineda MA; Meltzer PS; Walter-Rodriguez B; Roncalli M; Santoro A; Wang Y; Giaccone G
J Thorac Oncol; 2010 Sep; 5(9):1447-53. PubMed ID: 20651610
[TBL] [Abstract][Full Text] [Related]
8. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G
Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the new TNM-staging system for thymic malignancies: impact on indication and survival.
Ried M; Eicher MM; Neu R; Sziklavari Z; Hofmann HS
World J Surg Oncol; 2017 Dec; 15(1):214. PubMed ID: 29197400
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms.
Kojika M; Ishii G; Yoshida J; Nishimura M; Hishida T; Ota SJ; Murata Y; Nagai K; Ochiai A
Mod Pathol; 2009 Oct; 22(10):1341-50. PubMed ID: 19648882
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of amplification of chromosome 1 with histologic typing of thymic epithelial tumors].
Ma YQ; Zhang C; Cui WL; Gulinaer A; Zhang W; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):820-4. PubMed ID: 22336207
[TBL] [Abstract][Full Text] [Related]
12. Thymic carcinoma: proposal for pathological TNM and staging.
Tsuchiya R; Koga K; Matsuno Y; Mukai K; Shimosato Y
Pathol Int; 1994 Jul; 44(7):505-12. PubMed ID: 7921194
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic analysis of 52 cases of thymic epithelial tumor].
Ma YQ; Miao N; Abulajiang G; Li QX; Liu X; Zhang W; Wang CF; Wang J
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):249-54. PubMed ID: 20654124
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 expression level in different thymoma stages and thymic carcinoma: a meta-analysis.
Chen HF; Wu LX; Li XF; Zhu YC; Pan WW; Wang WX; Xu CW; Huang JH; Wu MH; Du KQ
Tumori; 2020 Aug; 106(4):306-311. PubMed ID: 32366210
[TBL] [Abstract][Full Text] [Related]
15. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of [18F]fluoro-2-deoxy-D-glucose positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors.
Igai H; Matsuura N; Tarumi S; Chang SS; Misaki N; Go T; Ishikawa S; Yokomise H
Eur J Cardiothorac Surg; 2011 Jul; 40(1):143-5. PubMed ID: 20951602
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma.
Kishibuchi R; Kondo K; Soejima S; Tsuboi M; Kajiura K; Kawakami Y; Kawakita N; Sawada T; Toba H; Yoshida M; Takizawa H; Tangoku A
Int J Oncol; 2020 Jan; 56(1):315-326. PubMed ID: 31746370
[TBL] [Abstract][Full Text] [Related]
18. Tumor-related gene expression levels in thymic carcinoma and Type B3 thymoma.
Karube Y; Kobayashi S; Maeda S; Sado T; Ishihama H; Chida M
J Cardiothorac Surg; 2016 May; 11(1):85. PubMed ID: 27387303
[TBL] [Abstract][Full Text] [Related]
19. Mutation Profile of Thymic Carcinoma and Thymic Neuroendocrine Tumor by Targeted Next-generation Sequencing.
Sakane T; Sakamoto Y; Masaki A; Murase T; Okuda K; Nakanishi R; Inagaki H
Clin Lung Cancer; 2021 Mar; 22(2):92-99.e4. PubMed ID: 33414055
[TBL] [Abstract][Full Text] [Related]
20. Discovery and validation of DNA methylation markers for overall survival prognosis in patients with thymic epithelial tumors.
Li S; Yuan Y; Xiao H; Dai J; Ye Y; Zhang Q; Zhang Z; Jiang Y; Luo J; Hu J; Chen C; Wang G
Clin Epigenetics; 2019 Mar; 11(1):38. PubMed ID: 30832724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
